Methasterone
| Clinical data | |
|---|---|
| Other names | Superdrol; Methyldrostanolone; Methasteron; 2α,17α-Dimethyl-4,5α-dihydrotestosterone; 2α,17α-Dimethyl-DHT; 2α,17α-Dimethyl-5α-androstan-17β-ol-3-one |
| Routes of administration | oral |
| Drug class | Androgen; Anabolic steroid |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | ≈50% |
| Metabolism | Liver |
| Elimination half-life | 8–12 hours |
| Excretion | Urine |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C21H34O2 |
| Molar mass | 318.501 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
Methasterone, also known as methyldrostanolone and known by the nickname Superdrol, is a synthetic and orally active anabolic–androgenic steroid (AAS) which was never marketed for medical use. It was sold legally for 9 years as a body building supplement. Because of this lengthy time being legal it has more studies and references than most other designer steroids.